Mentalization and Self-Efficacy As Mediators Between Psychological Symptom Severity and Disabilities in Activities and Participation in Psychotherapy Patients
Overview
Affiliations
Background: Psychotherapy patients can be more or less disabled by their psychological symptoms. The present study investigated whether mentalization and self-efficacy contribute to the association between psychological symptom severity and disabilities in activities and participation.
Methods: The data of 216 psychotherapy inpatients were examined in a cross-sectional design. Bootstrapping-enhanced mediation analyses were performed to investigate whether self-efficacy and mentalization are mediators between psychological symptom severity and disabilities in activities and participation. The Hamburg Modules for the Assessment of Psychosocial Health-49 were used to measure psychological symptom severity and self-efficacy, mentalization was assessed with the Mentalization Questionnaire, and disabilities in activities and participation were operationalized with the ICF-Mental-A & P questionnaire.
Results: Mentalization as well as self-efficacy functioned as mediators between psychological symptom severity and disabilities in activities and participation (p < 0.05). They were equally strong mediators, and both remained significant mediators when statistically controlling for the other mediator (p < 0.05).
Conclusions: Mentalization as well as self-efficacy explain a significant proportion of the relationship between psychological symptom severity and disabilities in activities and participation. Working on mentalizing and self-efficacy might be important mechanisms to reduce disability due to symptoms. The cross-sectional design is a limitation of the study.
Krok D, Telka E, Falewicz A, Szczesniak M J Clin Med. 2024; 13(7).
PMID: 38610737 PMC: 11012918. DOI: 10.3390/jcm13071974.
Skliarova T, Pedersen H, Hafstad H, Rennemo Vaag J, Lara-Cabrera M, Havnen A Front Psychiatry. 2023; 14:1212961.
PMID: 38025439 PMC: 10657811. DOI: 10.3389/fpsyt.2023.1212961.
Dangerfield M, Decker L Front Psychiatry. 2023; 14:1206511.
PMID: 37469356 PMC: 10352583. DOI: 10.3389/fpsyt.2023.1206511.
Riedl D, Rothmund M, Grote V, Fischer M, Kampling H, Kruse J Front Psychiatry. 2023; 14:1150422.
PMID: 37252135 PMC: 10213326. DOI: 10.3389/fpsyt.2023.1150422.
Riedl D, Kampling H, Nolte T, Lampe A, Beutel M, Brahler E Diagnostics (Basel). 2023; 13(1).
PMID: 36611427 PMC: 9818984. DOI: 10.3390/diagnostics13010135.